Reporting guidelines are recommendations to help write up research clearly.
Your research will be used by people from different disciplines and backgrounds for decades to come. Reporting guidelines are community-created recommendations for describing what you did and what you found so that everyone can understand, repeat, apply, and synthesise your work. Although they recommend information to include in your manuscript, they don’t dictate how to order that information.
Most reporting guidelines consist of the full guidance (sometimes called an Explanation and Elaboration document) and a checklist. The full guidance provides detailed explanations and examples for each item, and the checklist allows you to demonstrate adherence to editors.
You can use reporting guidelines throughout your research process. However you use reporting guidelines, please cite them.
Writing manuscripts
Write confidently using a reporting guideline to quickly turn a blank page into a thorough and impactful manuscript.
Checking
Use a reporting checklist to demonstrate to an editor or peer reviewer that you have included everything. Many journals require completed checklists at submission.
Writing applications
Reporting guidelines can help you write funding applications, ethics applications, and protocols, but they won’t make design decisions for you!
Reporting guidelines are neither design nor quality appraisal tools.
Although reporting guidelines recommend information to include when writing up research, they do not mandate how to design research. Similarly, when reviewing literature, although you can use reporting guidelines to assess whether a manuscript is well reported, you cannot use them to appraise whether that study is well designed.
Key information
Reporting guideline acronym
CHEERS 2022
Provided for
Economic evaluations of health interventions
Relevant URLs (full-text if available)
Further information about the CHEERS Statement is available from: the International Society for Pharmacoeconomics and Outcomes (ISPOR) website
PubMed ID
Downloads
Bibliographic reference
Commonly used reporting guidelines
| STROBE | Observational Studies |
| PRISMA | Systematic reviews of trials |
| PRISMA-P | Systematic review protocols |
| CONSORT | Randomised trials |
| SPIRIT | Randomised trial protocols |
| SRQR | Qualitative Research |
| CARE | Case Reports |
| STARD | Diagnostic studies |
| TRIPOD+AI | Prediction Models |
| ARRIVE | Animal Research |
| SQUIRE | Quality Improvement |
| CHEERS | Economic Evaluations |
| Search all |
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S; CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.
This guideline was published simultaneously in the following journals. You can read the guideline in any of these journals using the links below.
Value Health. 2022;25(1):3-9. PMID: 35031096
BMC Med. 2022;20(1):23. PMID: 35022047
J Manag Care Spec Pharm. 2022:1-10. PMID: 35016547
BMJ. 2022;376:e067975. PMID: 35017145
Pharmacoeconomics. 2022. PMID: 35015272
Appl Health Econ Health Policy. 2022. PMID: 35015207
Int J Technol Assess Health Care. 2022;38(1):e13. PMID: 35007499
J Med Econ. 2022;25(sup1):1-7. PMID: 35012427
BJOG. 2022;129(3):336-344. PMID: 35014160
Eur J Health Econ. 2022. PMID: 35084632
BMC Health Serv Res. 2022;22(1):114. PMID: 35081957
BMC Public Health. 2022;22(1):179. PMID: 35081920
Health Policy OPEN. Volume 3, December 2022.
MDM Policy Pract. 2022;7(1):23814683211061097. PMID: 35036563
Clin Ther. 2022;S0149-2918(22)00016-9. PMID: 35168801
Additional information
Language
English
Availability in additional languages
CHEERS 2022
Augustovski F, García Martí S, Espinoza MA, Palacios A, Husereau D, Pichon-Riviere A. Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: adaptación al español de la lista de comprobación CHEERS 2022. Value Health Reg Issues. 2022;27:110-114. Spanish translation
Saygin Avşar T, Yiğit V, Yiğit A, Oğuz Arı H, Tecirli G, Dilmaç E, Husereau D. Konsolide Sağlık Ekonomisi Değerlendirme Raporlama Standartları Türkçe: Sağlık Hizmetlerinin Ekonomik Değerlendirmesinde Raporlama Standartlarının Türkiye Uyarlaması. Turkiye Klinikleri J Health Sci. 2023. Turkish translation
Guertin JR, Bénard E, Aubin M-C, Diaby V, Dragomir A, Latimer E, Tarride J-E, Husereau D. French Translation of the 2022 Version of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. Canadian Journal of Health Technologies. 2023;3(10). French translation
Don Husereau, Michael Drummond, Federico Augustovski, Esther de Bekker-Grob, Andrew H Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C Daniel Mullins, Stavros Petrou, Raoh-Fang Pwu, Sophie Staniszewska, 肖月(译者), 邱英鹏(译者), 史黎炜(译者), 张治国(译者), 张歆(译者), 王海银(译者), 翟铁民(译者) on behalf of CHEERS 2022 ISPOR Good Research Practices Task Force. 卫生经济学评价报告标准共识2022（CHEERS 2022)：卫生经济学评价报告指导意见更新版. 英国医学杂志中文版. 2022:25(8):460-465. Chinese translation
Shiroiwa T, Noto S, Kobayashi M, Fukuda T. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration. Journal of the National Institute of Public Health. 2023;72(4):344-369. Japanese translation
Werbrouck A, de Bekker-Grob E, Al M, Putman K, Willems R. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation. Expert Rev Pharmacoecon Outcomes Res. 2024;24(4):551-557. Dutch translation
CHEERS 2013
The CHEERS Statement (2013) has been translated into Spanish, Chinese,
Japanese (PDF) and Portuguese. \
Study design
- Economic evaluations
Clinical area
- No clinical specialty specified
Applies to the whole report or to individual sections of the report?
- Whole report
Reporting guideline website URL
Previous versions of this guideline / Guideline history
CHEERS 2013
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
This guideline was published simultaneously in 10 journals.
Eur J Health Econ. 2013;14(3):367-372. PMID: 23526140
Value Health. 2013;16(2):e1-e5. PMID: 23538200
Clin Ther. 2013;35(4):356-363. PMID: 23537754
Cost Eff Resour Alloc. 2013;11(1):6. PMID: 23531194
BMC Med. 2013;11:80. PMID: 23531108
BMJ. 2013;346:f1049. PMID: 23529982
Pharmacoeconomics. 2013;31(5):361-367. PMID: 23529207
J Med Econ. 2013;16(6):713-719. PMID: 23521434
Int J Technol Assess Health Care. 2013;29(2):117-122. PMID: 23587340
BJOG. 2013;120(6):765-770. PMID: 23565948
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; on behalf of the ISPOR Health Economic Evaluation Publication Guidelines - CHEERS Good Reporting Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)- Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231-250. PMID: 23538175
Other
Additional Information
Read a commentary advocating for greater public involvement in health economic evaluation, including a guide for patient representatives and organisations (available in additional file 1 of the supplementary information) following suggestions made by the CHEERS 2022 Public Reference Group.